Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer

Investigational New Drugs ◽

10.1007/s10637-012-9824-8 ◽

2012 ◽

Vol 31 (1) ◽

pp. 152-159 ◽

Author(s):

Keun Seok Lee ◽

In Hae Park ◽

Byung-Ho Nam ◽

Jungsil Ro

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pretreated Patients

Download Full-text

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6601485 ◽

2004 ◽

Vol 90 (1) ◽

pp. 36-40 ◽

Author(s):

S Gori ◽

M Colozza ◽

A M Mosconi ◽

E Franceschi ◽

C Basurto ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Paclitaxel ◽

Pretreated Patients

Download Full-text

A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000722 ◽

2019 ◽

Vol 30 (4) ◽

pp. 394-401

Author(s):

Joachim Bischoff ◽

Jana Barinoff ◽

Christoph Mundhenke ◽

Dirk O. Bauerschlag ◽

Serban-Dan Costa ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Randomized Phase Ii ◽

Pretreated Patients ◽

Download Full-text

PYTHIA: A phase II study of palbociclib plus fulvestrant for pretreated patients with ER+/HER2- metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdx365.085 ◽

2017 ◽

Vol 28 ◽

pp. v107

Author(s):

D. Zardavas ◽

M. Regan ◽

R. Maibach ◽

B. Ruepp ◽

A. Hiltbrunner ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pretreated Patients

Download Full-text

Abstract P2-17-02: A phase II study of bevacizumab in combination with modified FOLFOX6 in heavily pretreated patients with HER2-negative metastatic breast cancer

10.1158/1538-7445.sabcs14-p2-17-02 ◽

2015 ◽

Author(s):

Ting Li ◽

Biyun Wang ◽

Xichun Hu ◽

Zhonghua Wang ◽

Jian Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Heavily Pretreated ◽

Pretreated Patients ◽

Modified Folfox6

Download Full-text

Abstract P6-11-16: PYTHIA: A phase II study of palbociclib plus fulvestrant versus placebo plus fulvestrant for pretreated patients with ER+/HER2- metastatic breast cancer

10.1158/1538-7445.sabcs16-p6-11-16 ◽

2017 ◽

Author(s):

D Zardavas ◽

M Regan ◽

R Maibach ◽

B Ruepp ◽

A Hiltbrunner ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pretreated Patients

Download Full-text

0187 Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group

10.1016/s0960-9776(09)70210-3 ◽

2009 ◽

Vol 18 ◽

pp. S66

Author(s):

F. Zagouri ◽

A. Bamias ◽

P. Papakostas ◽

A. Karadimou ◽

E. Bournakis ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Second Line ◽

Oncology Group ◽

Weekly Docetaxel ◽

Pretreated Patients ◽

Line Chemotherapy

Download Full-text

Salvage Chemotherapy with Gemcitabine and Oxaliplatin in Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

Oncology ◽

10.1159/000096248 ◽

2006 ◽

Vol 70 (4) ◽

pp. 273-279 ◽

Author(s):

S. Kakolyris ◽

K. Kalbakis ◽

A. Potamianou ◽

N. Malamos ◽

L. Vamvakas ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Salvage Chemotherapy ◽

Multicenter Phase ◽

Heavily Pretreated ◽

Pretreated Patients

Download Full-text

Phase II Study of Trastuzumab plus Gemcitabine in Chemotherapy-Pretreated Patients with Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2004.n.019 ◽

2004 ◽

Vol 5 (2) ◽

pp. 142-147 ◽

Author(s):

Joyce A. O'Shaughnessy ◽

Sasha Vukelja ◽

Thomas Marsland ◽

Gary Kimmel ◽

Suresh Ratnam ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pretreated Patients

Download Full-text

Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80299-4 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

J Baselga

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Schedule ◽

Download Full-text

Randomised Phase II Study of Palbociclib Plus Exemestane with GnRH Agonist Versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3414442 ◽

2019 ◽

Author(s):

Yeon Hee Park ◽

Tae-Yong Kim ◽

Gun Min Kim ◽

Kyung Hae Jung ◽

Seok Yun Kang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Gnrh Agonist ◽

Hormone Receptor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Premenopausal Women ◽

Hormone Receptor Positive

Download Full-text